Dr Barry Kenny joins as Non-Executive Director Dr Andrew Southan, COO, appointed Executive Director Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery [...]
Scientific Advisory Board will provide scientific oversight and strategic advice to support Metrion’s ion channel screening, cardiac safety testing, and native tissue and human stem cell translational [...]
Metrion Biosciences awarded £200k funding under Innovate UK Biomedical Catalyst Feasibility Award Funding will support further development of recently acquired small molecule assets for treatment of autoimmune [...]
Acquired intellectual property rights have potential application in a variety of clinical indications, including auto-immune disorders and neurodegenerative diseases. Metrion now owns all patented and unpatented IP [...]
Metrion Biosciences today announced a collaboration with Chris Mathes PhD, founder of Candidate Biopharma Advisors, to broaden Metrion's exposure in the North American market. Chris is well [...]
Cambridge, UK, 16 January 2018: Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, and online investment platform SyndicateRoom, announced today the [...]
Thanks to our Customers: the Metrion Biosciences team would like to thank our customers for placing business with us in 2017. We take great pride in providing [...]
Metrion Biosciences and Concept Life Sciences would like to invite you to their USA Integrated Discovery spotlight session focussing on overcoming challenges in ion channel drug discovery [...]
LifeArc and Metrion Biosciences extend partnership agreement to support LifeArc's neuroscience small molecule drug discovery programme. Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug [...]
Metrion Biosciences will be attending the Safety Pharmacology Society meeting in Berlin, 24-27 September 2017. John Ridley will be on booth #216, contact him here if you [...]
Q2 2017 was another productive quarter for the Metrion Biosciences team. Our stand-alone CRO sales continued on an upward trajectory, with both April and June revenues beating [...]
Invitation extended to external scientists to attend TRP channel focused presentation by leading UK academic. The fourth presentation in Metrion Biosciences external speaker series will be given [...]
Metrion Biosciences is pleased to announce it will be attending the forthcoming 2017 BIO International Convention in San Diego, CA ( 19th - 22nd June). Metrion will be represented by [...]
Metrion appoints Chief Operating Officer and Head of Business Development. The full press release can be found here.
Metrion announce collaboration to search for novel modulators of ion channels with proven therapeutic potential. The full press release can be found here.
Metrion's collaboration with Assay.Works featured in the April 2017 edition of Drug Discovery News. The article can be found here.
Metrion Biosciences' review of Q1 2017 can be found here.
The fourth Cambridge Ion Channel Forum will take place on 21st April 2017.
Metrion and Concept Life Sciences partner to offer fully integrated ion channel drug discovery services.
Metrion and Assay.Works form partnership to offer expanded ion channel research capability.
Metrion Biosciences' 2016 year end review LinkedIn article can be found here.